Inventor · disambiguated record
Vera Pütter
Also filed as: PÜTTER VERA
4 granted patents·6 pending applications·7 citations·filing 2012–2021
64Inventor score
Top patents by PatentIndex Score
10 records- 0178US10266548B2Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2017·Granted Apr 23, 2019·2 cites·2 claims
- 0278US9643953B2Substituted benzylpyrazolesBAYER IP GMBH·Filed 2012·Granted May 9, 2017·5 cites·10 claims
- 0364US10604532B2Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2019·Granted Mar 31, 2020·0 cites·6 claims
- 0460US2024287048A1Substituted acyl sulfonamides for treating cancerBROAD INST INC·Filed 2021·Application pending·0 cites
- 0553US2017275267A1Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancerBayer Pharma AG·Filed 2017·Application pending·0 cites
- 0652US2014249133A1Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseasesBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 0751US2016046610A13-heteroaryl substituted indazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 0851US2024279207A1Substituted acyl sulfonamides for treating cancerBROAD INST INC·Filed 2021·Application pending·0 cites
- 0948US2015141372A1Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancerBayer Pharma AG·Filed 2013·Application pending·0 cites
- 1043US12357603B2Acyl sulfonamides for treating cancerBAYER AG·Filed 2020·Granted Jul 15, 2025·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Vera Pütter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →